Vakaramoko Diaby to Risk Assessment
This is a "connection" page, showing publications Vakaramoko Diaby has written about Risk Assessment.
Connection Strength
0.310
-
Okere AN, Sanogo V, Alqhtani H, Diaby V. Identification of risk factors of 30-day readmission and 180-day in-hospital mortality, and its corresponding relative importance in patients with Ischemic heart disease: a machine learning approach. Expert Rev Pharmacoecon Outcomes Res. 2021 Oct; 21(5):1043-1048.
Score: 0.135
-
Nkemdirim Okere A, Sanogo V, Balkrishnan R, Diaby V. A quantitative analysis of the effect of continuity of care on 30-day readmission and in-hospital mortality among patients with acute ischemic stroke. J Stroke Cerebrovasc Dis. 2020 Sep; 29(9):105053.
Score: 0.131
-
Winterstein AG, Ewig CLY, Wang Y, Smolinski NE, Toyserkani GA, LaCivita C, Lackey L, Eggers S, Zhou EH, Diaby V, Sarayani A, Thai T, Maro JC, Rasmussen SA. Teratogenic Risk Impact and Mitigation (TRIM): Study Protocol for the Development of a Decision Support Tool to Prioritize Medications for Risk Mitigation. Drug Saf. 2025 Feb; 48(2):107-117.
Score: 0.044